Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Tie-2 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 3 publications
Supplier: R&D Systems MAB313
This item is not returnable.
View return policy
Description
Tie-2 Monoclonal specifically detects Tie-2 in Human samples. It is validated for Western Blot.Specifications
Tie-2 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
angiopoietin-1 receptor, CD202B, CD202b antigen, EC 2.7.10, EC 2.7.10.1, hTIE2, p140 TEK, soluble TIE2 variant 1, soluble TIE2 variant 2, TEK, TEK tyrosine kinase, endothelial, Tie2, TIE-2, TIE2CD202b, Tunica interna endothelial cell kinase, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE-2, venous malformations, multiple cutaneous and mucosal, VMCM, VMCM1 | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
7010 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Western Blot | |
83711 | |
Western Blot 1 ug/mL | |
AAA61139 | |
TEK | |
Mouse myeloma cell line NS0-derived recombinant human Tie-2 Ala23-Lys745 Accession # AAA61139 | |
500 μg | |
Primary | |
Detects human Tie-2 in direct ELISAs and Western blots. Shows approximately 15% cross-reactivity with recombinant mouse Tie-2 and less than 1% cross-reactivity with recombinant human Tie-1. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction